Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1980451564', 'doi': 'https://doi.org/10.1016/j.bmcl.2007.03.098', 'title': 'Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: Close analogs of JANUVIA™ (sitagliptin phosphate)', 'display_name': 'Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: Close analogs of JANUVIA™ (sitagliptin phosphate)', 'publication_year': 2007, 'publication_date': '2007-06-01', 'ids': {'openalex': 'https://openalex.org/W1980451564', 'doi': 'https://doi.org/10.1016/j.bmcl.2007.03.098', 'mag': '1980451564', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/17434732'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.bmcl.2007.03.098', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30970080', 'display_name': 'Bioorganic & Medicinal Chemistry Letters', 'issn_l': '0960-894X', 'issn': ['0960-894X', '1464-3405'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5061949196', 'display_name': 'Dooseop Kim', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dooseop Kim', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078000843', 'display_name': 'Jennifer E. Kowalchick', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jennifer E. Kowalchick', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050475544', 'display_name': 'Scott D. Edmondson', 'orcid': 'https://orcid.org/0000-0003-4865-2561'}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Scott D. Edmondson', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5086735835', 'display_name': 'Anthony Mastracchio', 'orcid': 'https://orcid.org/0000-0002-8180-9834'}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Anthony Mastracchio', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009592764', 'display_name': 'Jinyou Xu', 'orcid': 'https://orcid.org/0000-0002-2405-6346'}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jinyou Xu', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075553198', 'display_name': 'George J. Eiermann', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'George J. Eiermann', 'raw_affiliation_strings': ['Dept of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA'], 'affiliations': [{'raw_affiliation_string': 'Dept of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5046164159', 'display_name': 'Barbara Leiting', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Barbara Leiting', 'raw_affiliation_strings': ['Dept of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA'], 'affiliations': [{'raw_affiliation_string': 'Dept of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026367140', 'display_name': 'Joseph K. Wu', 'orcid': 'https://orcid.org/0009-0006-0924-6922'}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Joseph K. Wu', 'raw_affiliation_strings': ['Dept of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA'], 'affiliations': [{'raw_affiliation_string': 'Dept of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044575451', 'display_name': 'KellyAnn D. Pryor', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'KellyAnn D. Pryor', 'raw_affiliation_strings': ['Dept of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA'], 'affiliations': [{'raw_affiliation_string': 'Dept of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014966089', 'display_name': 'Reshma A. Patel', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Reshma A. Patel', 'raw_affiliation_strings': ['Dept of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA'], 'affiliations': [{'raw_affiliation_string': 'Dept of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5064771805', 'display_name': 'Huaibing He', 'orcid': 'https://orcid.org/0000-0001-7675-1722'}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Huaibing He', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034951389', 'display_name': 'Kathryn A. Lyons', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kathryn A. Lyons', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017935803', 'display_name': 'Nancy A. Thornberry', 'orcid': 'https://orcid.org/0000-0003-1935-7811'}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nancy A. Thornberry', 'raw_affiliation_strings': ['Dept of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA'], 'affiliations': [{'raw_affiliation_string': 'Dept of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5031274832', 'display_name': 'Ann E. Weber', 'orcid': 'https://orcid.org/0000-0001-5388-8064'}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'MSD (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ann E. Weber', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.', 'institution_ids': ['https://openalex.org/I1285764155']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3660, 'currency': 'USD', 'value_usd': 3660, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 2.785, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 58, 'citation_normalized_percentile': {'value': 0.909723, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 94, 'max': 95}, 'biblio': {'volume': '17', 'issue': '12', 'first_page': '3373', 'last_page': '3377'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12505', 'display_name': 'Role of Fibroblast Activation in Cancer Progression', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12505', 'display_name': 'Role of Fibroblast Activation in Cancer Progression', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 0.9963, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10814', 'display_name': 'Role of Neuropeptides in Physiology and Disease', 'score': 0.9912, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/sitagliptin-phosphate', 'display_name': 'Sitagliptin Phosphate', 'score': 0.90556884}, {'id': 'https://openalex.org/keywords/dipeptidyl-peptidase', 'display_name': 'Dipeptidyl peptidase', 'score': 0.7638079}, {'id': 'https://openalex.org/keywords/saxagliptin', 'display_name': 'Saxagliptin', 'score': 0.7212273}, {'id': 'https://openalex.org/keywords/dipeptidyl-peptidase-4-inhibitor', 'display_name': 'Dipeptidyl peptidase-4 inhibitor', 'score': 0.5965098}, {'id': 'https://openalex.org/keywords/dipeptidyl-peptidase-4-inhibitors', 'display_name': 'Dipeptidyl Peptidase-4 Inhibitors', 'score': 0.578414}, {'id': 'https://openalex.org/keywords/vildagliptin', 'display_name': 'Vildagliptin', 'score': 0.41489887}], 'concepts': [{'id': 'https://openalex.org/C2779284873', 'wikidata': 'https://www.wikidata.org/wiki/Q419832', 'display_name': 'Sitagliptin', 'level': 4, 'score': 0.97610736}, {'id': 'https://openalex.org/C2910260750', 'wikidata': 'https://www.wikidata.org/wiki/Q419832', 'display_name': 'Sitagliptin Phosphate', 'level': 5, 'score': 0.90556884}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.89448464}, {'id': 'https://openalex.org/C2781469919', 'wikidata': 'https://www.wikidata.org/wiki/Q5279728', 'display_name': 'Dipeptidyl peptidase', 'level': 3, 'score': 0.7638079}, {'id': 'https://openalex.org/C2780282729', 'wikidata': 'https://www.wikidata.org/wiki/Q3121121', 'display_name': 'Saxagliptin', 'level': 5, 'score': 0.7212273}, {'id': 'https://openalex.org/C156490143', 'wikidata': 'https://www.wikidata.org/wiki/Q412214', 'display_name': 'Dipeptidyl peptidase-4', 'level': 4, 'score': 0.655294}, {'id': 'https://openalex.org/C2778763485', 'wikidata': 'https://www.wikidata.org/wiki/Q419770', 'display_name': 'Dipeptidyl peptidase-4 inhibitor', 'level': 4, 'score': 0.5965098}, {'id': 'https://openalex.org/C2776980637', 'wikidata': 'https://www.wikidata.org/wiki/Q427492', 'display_name': 'Enzyme inhibitor', 'level': 3, 'score': 0.50128007}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.49093273}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.42980936}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.42892963}, {'id': 'https://openalex.org/C2776453732', 'wikidata': 'https://www.wikidata.org/wiki/Q421042', 'display_name': 'Vildagliptin', 'level': 4, 'score': 0.41489887}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.3844995}, {'id': 'https://openalex.org/C21951064', 'wikidata': 'https://www.wikidata.org/wiki/Q899212', 'display_name': 'Combinatorial chemistry', 'level': 1, 'score': 0.33809912}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.1674124}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.096156985}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.06904915}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000577', 'descriptor_name': 'Amides', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': True}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': True}, {'descriptor_ui': 'D011480', 'descriptor_name': 'Protease Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': True}, {'descriptor_ui': 'D000577', 'descriptor_name': 'Amides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011480', 'descriptor_name': 'Protease Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011480', 'descriptor_name': 'Protease Inhibitors', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068900', 'descriptor_name': 'Sitagliptin Phosphate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013329', 'descriptor_name': 'Structure-Activity Relationship', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.bmcl.2007.03.098', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30970080', 'display_name': 'Bioorganic & Medicinal Chemistry Letters', 'issn_l': '0960-894X', 'issn': ['0960-894X', '1464-3405'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/17434732', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Clean water and sanitation', 'id': 'https://metadata.un.org/sdg/6', 'score': 0.43}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 36, 'referenced_works': ['https://openalex.org/W123502426', 'https://openalex.org/W1237155366', 'https://openalex.org/W1553821695', 'https://openalex.org/W1965799612', 'https://openalex.org/W1977471179', 'https://openalex.org/W1978953702', 'https://openalex.org/W1991635121', 'https://openalex.org/W1993287695', 'https://openalex.org/W1994174156', 'https://openalex.org/W1998817071', 'https://openalex.org/W2001739257', 'https://openalex.org/W2002145465', 'https://openalex.org/W2011778618', 'https://openalex.org/W2027725447', 'https://openalex.org/W2028707869', 'https://openalex.org/W2049268367', 'https://openalex.org/W2062334057', 'https://openalex.org/W2078021048', 'https://openalex.org/W2083473802', 'https://openalex.org/W2084142744', 'https://openalex.org/W2087063469', 'https://openalex.org/W2097998765', 'https://openalex.org/W2109157463', 'https://openalex.org/W2116480916', 'https://openalex.org/W2122101131', 'https://openalex.org/W2135162469', 'https://openalex.org/W2143014102', 'https://openalex.org/W2145884719', 'https://openalex.org/W2149461013', 'https://openalex.org/W2149794013', 'https://openalex.org/W2154615287', 'https://openalex.org/W2160139718', 'https://openalex.org/W2169009504', 'https://openalex.org/W2949720238', 'https://openalex.org/W4230178491', 'https://openalex.org/W4234825176'], 'related_works': ['https://openalex.org/W4288042649', 'https://openalex.org/W3149248637', 'https://openalex.org/W2748536545', 'https://openalex.org/W2595888593', 'https://openalex.org/W2317793094', 'https://openalex.org/W2180498869', 'https://openalex.org/W2083821725', 'https://openalex.org/W2038380378', 'https://openalex.org/W2017061308', 'https://openalex.org/W1980451564'], 'abstract_inverted_index': {'A': [0], 'series': [1], 'of': [2, 24, 34], 'beta-aminoamides': [3], 'bearing': [4], 'triazolopiperazines': [5], 'has': [6], 'been': [7], 'prepared': [8], 'and': [9], 'evaluated': [10], 'as': [11], 'potent,': [12], 'selective,': [13], 'orally': [14], 'active': [15], 'dipeptidyl': [16], 'peptidase': [17], 'IV': [18], '(DPP-4)': [19], 'inhibitors.': [20], 'Efforts': [21], 'at': [22], 'optimization': [23], 'the': [25, 32], 'beta-aminoamide': [26], 'series,': [27], 'which': [28], 'ultimately': [29], 'led': [30], 'to': [31], 'discovery': [33], 'JANUVIA': [35], '(sitagliptin': [36], 'phosphate,': [37], 'compound': [38], '1),': [39], 'are': [40], 'described.': [41]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1980451564', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 4}, {'year': 2022, 'cited_by_count': 3}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 3}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 4}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 3}, {'year': 2014, 'cited_by_count': 7}, {'year': 2013, 'cited_by_count': 2}, {'year': 2012, 'cited_by_count': 4}], 'updated_date': '2024-09-12T20:56:21.737167', 'created_date': '2016-06-24'}